IP Library Granted Patent US 11,021,525
Granted Patent B2
US 11,021,525 · App. 14/735,985 · Granted Jun 1, 2021

Synthetic transcription factor and uses thereof

Inventors: Howard H. Chou (Berkeley, CA); Jay D. Keasling (Berkeley, CA); Sergey Zotchev (Trondheim, NO)
Assignee: The Regents of the University of California
C07K14/4702C07K2319/00C07K2319/70C07K2319/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,021,525
App. No.
14/735,985
Granted
Jun 1, 2021
Kind
B2
Abstract

The present invention provides for a synthetic transcription factor (TF) comprising a first peptide capable of binding a target ligand, a second peptide capable of binding a target DNA, and a peptide linker linking the first and second peptides. The present invention also provide for a system for modulating the mutagenesis frequency of a host cell. The host cell has a mutator rate (R) which is inversely proportional to a phenotypic trait (P).

Claims (15)

1. A system for modulating mutagenesis frequency of a host cell, comprising a host cell comprising: (a) a synthetic transcription factor (TF) comprising a first peptide capable of binding a target ligand, a second peptide capable of binding a target DNA, and a peptide linker linking the first and second peptides, wherein the first peptide and the second peptide are from different proteins, and (b) a mutator module comprising a target promoter operably linked to a gene that is capable of increasing a mutation rate of the host cell; wherein the host cell has a mutator rate (R) which is inversely proportional to a phenotypic trait (P); wherein the first peptide is a ligand-binding domain of Idi, Idi1 or Erg20, and P is isoprenoid or lycopene production, and (i) the second peptide is a DNA-binding domain (DBD) of AraC and the target promoter is an araBAD promoter and the host cell is a prokaryotic cell, or (ii) the second peptide is a DNA-binding domain (DBD) of Gal 4 and the target promoter is a GAL promoter and the host cell is a yeast cell.

2. The system of claim 1 wherein the host cell comprises a nucleic acid comprising a nucleotide sequence encoding the synthetic TF.

3. The system of claim 2 wherein the host cell comprises a vector capable of stable maintenance of the nucleic acid.

4. The system of claim 3 wherein the vector is an expression vector.

5. The system of claim 1 , wherein (i) when the host cell is a prokaryotic cell the gene that is capable of increasing a mutation rate of the host cell is Escherichia coli mutD 5 , Bacillus subtilis mutM, Pseudomona aeruginosa mutS, Pseudomonas aeruginosa mutL, or Synechococcus sp. mutS, and (ii) when the host cell is a yeast cell the gene that is capable of increasing a mutation rate of the host cell is Saccharomyces cerevisiae msh2, or Saccharomyces cerevisiae him1.

6. The system of claim 1 , wherein the first peptide is a ligand-binding domain of Idi and the second peptide is a DNA-binding domain (DBD) of AraC and the target promoter is the araBAD promoter or the second peptide is a DNA-binding domain (DBD) of Gal4 and the target promoter is a GAL promoter.

7. The system of claim 6 , wherein the GAL promoter is P GAL10 .

8. The system of claim 1 , wherein the first peptide is a ligand-binding domain of Idi, Idi1 or Erg20, and the second peptide is a DNA-binding domain (DBD) of Gal4 and the target promoter is a GAL promoter.

9. The system of claim 8 , wherein the GAL promoter is P GAL10 .

10. The system of claim 1 , wherein the host cell is a prokaryotic cell which is a species of Escherichia, Enterobacter, Azotobacter, Erwinia, Bacillus, Pseudomonas, Klebsiella, Proteus, Salmonella, Serratia, Shigella, Rhizobia, Vitreoscilla , or Paracoccus.

11. The system of claim 10 , wherein the prokaryotic cell is a species of Escherichia.

12. The system of claim 11 , wherein the prokaryotic cell is Escherichia coli.

13. The system of claim 1 , wherein the host cell is a yeast cell which is a species of Saccharomyces or Candida.

14. The system of claim 13 , wherein the yeast cell is a species of Saccharomyces.

15. The system of claim 14 , wherein the yeast cell is Saccharomyces cerevisiae.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 11, 2015
From: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 036335/0554 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2015
From: CHOU, HOWARD H.; KEASLING, JAY D.; ZOTCHEV, SERGEY
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 035957/0843 →
Continuity (3)
Continuation PCTUS2013074214 · Dec 10, 2013
Provisional Application 61735507 · Dec 10, 2012
Related Publication 20150353614A1 · Dec 10, 2015